Shadi Tabibian: Low FVIII Does Not Always Mean Hemophilia A
Shadi Tabibian, Deputy of research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn about a recent article by Emmanuel J. Favaloro et al., published in Seminars in Thrombosis and Hemostasis, adding:
“Low FVIII does not always mean hemophilia A.
One important diagnostic pitfall is von Willebrand disease type 2N (VWD 2N), in which FVIII:C is disproportionately low while VWF studies may be normal or only mildly reduced.
In these cases, a low FVIII:C and VWF:Ag ratio (less than 0.7) should raise suspicion for type 2N VWD rather than automatically labeling the patient as hemophilia A.
Key takeaway:
When FVIII appears discordantly low, VWF:FVIIIB assay (or molecular testing) is essential for confirmation.
Correct distinction matters, because treatment approach differs between VWD type 2N and hemophilia A.”
Title: 100 Years of von Willebrand Disease: The Journey to Contemporary Diagnostic Pathways—An Illustrative Case-Based Narrative Review
Authors: Emmanuel J. Favaloro, Leonardo Pasalic, Jennifer Curnow

Other posts featuring Shadi Tabibian on Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments